Clinical Communications
Measuring total IgE is useful in detecting exacerbations in patients with allergic bronchopulmonary aspergillosis receiving omalizumab

https://doi.org/10.1016/j.jaip.2015.10.020Get rights and content

First page preview

First page preview
Click to open first page preview

References (10)

There are more references available in the full text version of this article.

Cited by (0)

The research activity of I.B. was partly supported by Instituto de Salud Carlos III – AES 2013, Programme Juan Rodés JR13/012.

Conflicts of interest: I. Bobolea has received payments from Novartis Farmaceutica for lectures, consultancy, and traveling to scientific meetings. C. F. Rodriguez has received travel support from National Congress, SEAIC (Allergy Society in Spain). C. M. Moreno has received payments from Novartis Farmaceutica for lectures, consultancy, and traveling to scientific meetings; consultancy fees from Boehringer Ingelheim and GlaxoSmithKline; has provided expert testimony for Chiesi; has received lecture fees from Novartis and Teva; has received payment for the development of educational presentations from GlaxoSmithKline; and has received travel support from Teva. The rest of the authors declare that they have no relevant conflicts of interest.

View full text